Home » Drug Delivery » Injectable Drug Delivery » Wirelessly Enabled Injection Devices to 2022

Wirelessly Enabled Injection Devices to 2022


wirelessly enabled injection devices   Wirelessly Enabled Injection Devices  •  Published February 2017  •  Catalog no. WEJ874F17  •  Price US $2,850


For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient’s quality-of-life. Wirelessly enabled devices – drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs – are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. Many of the current generation of wirelessly enabled injection devices are designed to communicate with a smartphone over a Bluetooth connection. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

 

Bar_Graph  Wireless Injection Device Report Brochure (Download PDF)

Blue document    Wireless Injection Device Report Order Form (Download PDF)


Wirelessly Enabled Injection Devices – What You Will Learn

• What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
• What benefits do wirelessly enabled drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
• What therapeutic areas are the current focus of wirelessly enabled devices?
• Who are the companies behind the growth of wirelessly enabled injection devices? What are their development activities and corporate alliances and affiliations
• What is the importance of pharma-device alliances and design partnerships on wirelessly enabled drug injection device commercialization and market access?
• What does the current market for wirelessly enabled drug injection devices look like? What will it look like in 2022?
• What are the key market drivers for the growth of wirelessly enabled injection devices?


Wirelessly Enabled Injection Devices – Summary of Contents

Executive Summary

Wireless Injection Devices – The Opportunity

Injectable Device Technology
Market Drivers
The Growth of Self-Administration
The Rise in Home Healthcare
The Cost of Non-Adherence
Biological Injectables and Patient Safety
The Impact of Developing Economies

Connectivity Technologies

Wireless Technologies
Bluetooth
Cellular
Near Field Communications
RFID

Wirelessly Enabled Device Classes

Wearable Devices
Handheld Devices
Device Segments
Non-drug Specific Connected Injectors
Automated Connected Injectors
Vendor-specific Connectivity Platforms
Third Party Connectivity Devices

Near-term Markets for Connected Injection Devices

Anaphylaxis
Autoimmune Disease
Cardiovascular
Diabetes
Hormone Replacement

Market Factors

Regulatory Issues
HIPAA and Patient Privacy
Data Security
Cybersecurity and Patient Safety
Patient Safety
User Training

Company Profiles


Useful Links

Wireless Medical Device Compliance